IPG CEO, Jay Ethridge to Speak at 2012 Oppenheimer Healthcare Conference
<0> IPG770-753-0046 </0>
IPG, the leading nationwide provider of Implantable Device Benefit Management (DBM) solutions, is pleased to announce their President and Chief Executive Officer, Jay Ethridge, will speak at the 23 Annual Oppenheimer Healthcare Conference in New York City. Ethridge will speak on, “Device Benefit Management Market Challenges and Solutions” on Wednesday, December 12, 2012 at 2:45 p.m. EST.
“In an industry where implantable medical devices represent $125 billion in health plan spend, there is an imperative need for greater transparency and the ability to manage the related risk and cost exposure,” Ethridge said. “At IPG, we have validated our ability to help health plans capitate their exposure and improve quality related to implantable device and surgical procedure utilization and spend. We are excited to continue to successfully implement the program nationwide as a strategic partner to our stakeholders, and Oppenheimer is a great opportunity to share our best practices in preparing for the future of device benefit management.”
As part of the original team at Eli Lilly & Co. that spun off to create Guidant Corporation in 1994, Jay was an integral part of the success that created one of the three leading manufacturers in the medical device industry, which was ultimately purchased by Boston Scientific in 2006 for more than $24 billion. Jay has a proven track record as a results-oriented senior level operating executive with a keen understanding of the implantable medical device industry. Jay joined IPG in May 2006 and has successfully lead IPG's transition into a professionally managed and capitalized organization with more than a 218% revenue growth rate over the past three years and well positioned for future growth.
For over 22 years, the Oppenheimer Healthcare Conference has become a highly valuable investor conference in this sector. Through formal company presentations and panels, attendees will gain insight from, and access to, industry leaders. The conference presents a core group of public and private companies who are leaders and pioneers in the pharmaceutical, biotechnology, medical device, healthcare facility, lifescience tools and diagnostics, health technology and distribution, provider and service industries.
As the leading provider of Device Benefit Management solutions, IPG streamlines the management and delivery of implantable medical devices by working directly with health plans, clinical providers and facilities, and medical device manufacturers through its implantable Device Benefit Management program. IPG handles device coordination, billing, replacement, tracking and other services for participating providers in their health plan partner’s ambulatory surgery center (ASC) and hospital network. The DBM program eliminates the complexity and the financial risks associated with the billing and reimbursement processes for providers, ensuring that patients receive innovative life-saving and life-enhancing device-intensive medical therapies. For more information about IPG, call us at 1-866-753-0046, or visit us on the web at .